secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioAtla, Inc. (BCAB)
CIK:        0001826892
Form:       8-K
Filed at:   2025-05-16T23:59:59+00:00
Accession:  0000950170-25-073688
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

BioAtla receives Nasdaq delisting notice for failing $10M equity requirement
----------------------------------------------------------------------------

- Stockholders' equity was $547K as of March 31, 2025, far below the $10M minimum for Nasdaq Global Market.
- Company has until June 26, 2025 to submit a compliance plan; Nasdaq may grant a 180-day extension.
- No immediate delisting effect; company intends to submit plan and take reasonable measures to regain compliance.
- Also failed alternative compliance standards based on market value of listed securities or total assets and revenue.
- Risk of delisting persists if plan is not accepted or compliance not regained within any granted period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826892/000095017025073688/0000950170-25-073688-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826892/000095017025073688/bcab-20250512.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-073688

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer